Oral and intravenous hydration in the treatment of orthostatic hypotension and postural tachycardia syndrome.
Hypotension, orthostatic
Hypovolemia
Orthostatic intolerance
Postural orthostatic tachycardia syndrome
Sodium chloride
Syncope, vasovagal
Journal
Autonomic neuroscience : basic & clinical
ISSN: 1872-7484
Titre abrégé: Auton Neurosci
Pays: Netherlands
ID NLM: 100909359
Informations de publication
Date de publication:
31 Jan 2022
31 Jan 2022
Historique:
received:
04
08
2021
revised:
07
12
2021
accepted:
25
01
2022
pubmed:
6
2
2022
medline:
6
2
2022
entrez:
5
2
2022
Statut:
aheadofprint
Résumé
Hydration with water and salt is the mainstay of treatment for autonomic nervous system disorders that impair orthostatic tolerance. The goal is to expand intravascular volume to compensate for the downward displacement of blood volume that occurs when standing and thereby sustain cerebral perfusion and restore quality of life. Despite strong consensus recommendations for salt supplementation as standard treatment of these disorders, published evidence of benefit is relatively weak, and no randomized clinical trials have occurred. This review summarizes the physiological rationale for hydration and evaluates the literature on oral and intravenous hydration in the treatment of neurogenic orthostatic hypotension, postural tachycardia syndrome, and recurrent vasovagal syncope. We conclude that oral salt replacement is indicated for treatment of neurogenic orthostatic hypotension because these patients have excessive renal sodium excretion, and for treatment of chronic orthostatic intolerance because these patients are often hypovolemic. As not all patients are able to tolerate sufficient oral hydration, there is also a role for intravenous volume-loading in severe cases of postural tachycardia syndrome. We offer guidance, based on review of the literature and the clinical judgment of a cardiologist and neurologist with experience treating autonomic disorders, regarding the option of ongoing intravenous hydration for treatment of severe, refractory cases of postural tachycardia syndrome.
Identifiants
pubmed: 35123367
pii: S1566-0702(22)00010-8
doi: 10.1016/j.autneu.2022.102951
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102951Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.